Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Naproxen in Juvenile Rheumatoid Arthritis
NCT00279747Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2000
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of meloxicam in juvenile idiopathic arthritis (JIA), sponsored by Boehringer Ingelheim. Started Sep 2000; status: completed.
02
Drugs
meloxicam
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT00279747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279747.